US Patent Issued Covering Applied NeuroSolutions, Inc.'s Mice With Human Tau

VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.appliedneurosolutions.com) today announced its founding scientist, Dr. Peter Davies, along with Dr. Karen Duff at Research Foundation for Mental Hygiene, Inc. (RFMH) were issued US patent number 7,161,060 entitled “Transgenic Mice Comprising a Genomic Human Tau Transgene.” The tau protein is believed to play a key role in the formation of tangles, one of the hallmark pathologies of Alzheimer’s disease (AD).

MORE ON THIS TOPIC